Laurus Labs informs about company updates

29 Oct 2022 Evaluate
Laurus Labs has informed that US Food and Drug Administration (USFDA) today completed a Pre-Approval Inspection (PAI) at its manufacturing facility at Unit-5, Parawada, Visakhapatnam, Andhra Pradesh. The inspection was conducted from 24th October 2022 to 28th October 2022. The company issued a Form 483 with one observation. The observation is procedural in nature. The Company will address the observation within stipulated timelines.

The above information is a part of company’s filings submitted to BSE.

Laurus Labs Share Price

1001.00 -3.30 (-0.33%)
16-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1782.80
Dr. Reddys Lab 1279.00
Cipla 1500.00
Zydus Lifesciences 913.90
Lupin 2089.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×